Milton C. Ault III - 06 Aug 2024 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
06 Aug 2024
Net transactions value
+$206
Form type
4
Filing time
14 Aug 2024, 18:01:00 UTC
Previous filing
05 Aug 2024
Next filing
21 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $206 +75 +0.1% $2.75* 77,268 06 Aug 2024 By Ault Lending, LLC F1
holding ALZN Common Stock 16,686 06 Aug 2024 Direct
holding ALZN Common Stock 99,619 06 Aug 2024 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 549 06 Aug 2024 By Ault Life Sciences Fund, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.